INDGN vs VIMTALABS: Stock Comparison

Indegene Limited vs Vimta Labs Ltd

Live data: 27 July 2026, 11:32 AM IST • Source: NSE and company filings

Indegene Limited is the larger company by market capitalisation. Indegene Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Vimta Labs Ltd shows a lower P/E, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indegene Limited and Vimta Labs Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDGN is more favourable on 6 of 13 scored metrics and VIMTALABS on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INDGN is the larger company
₹12,021 Cr vs ₹2,580 Cr
P/E Ratio
VIMTALABS has a lower P/E
0x vs 29.69x
P/B Ratio
VIMTALABS has a lower P/B
0x vs 3.79x
EPS
INDGN has higher earnings per share
₹16.6 vs ₹13.8
Dividend Yield
INDGN has a higher dividend yield
0.46% vs 0.35%
Revenue Growth (TTM YoY)
INDGN has faster revenue growth
32.8% vs 16.5%
EPS Growth (TTM YoY)
VIMTALABS has faster EPS growth
14.3% vs -32.3%
Qtr Sales Growth
INDGN has stronger quarterly sales growth
32.8% vs 20.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDGNVIMTALABS
SectorHealthcareHealthcare
IndustryHealthcare Research Analytics & TechnologyHealthcare Research Analytics & Technology

Price

MetricINDGNVIMTALABS
Live Price₹501.65₹585.4
Day Change1.83%2.62%
Volume34,1431.2 L
52-Week High₹596.8₹902.65
52-Week Low₹414₹376.05
Distance from 52W High-15.94%-35.15%

Valuation

MetricINDGNVIMTALABS
Market Cap₹12,021 Cr₹2,580 Cr
P/E Ratio29.69x0x
P/B Ratio3.79x0x
EPS₹16.6₹13.8
Book Value₹130.29₹77.2
Dividend Yield0.46%0.35%

Growth

MetricINDGNVIMTALABS
Revenue Growth (TTM YoY)32.8%16.5%
EPS Growth (TTM YoY)-32.3%14.3%
Qtr Sales Growth32.8%20.6%
Qtr Profit Growth-19.1%43%

Profitability & Leverage

MetricINDGNVIMTALABS
ROE14.4%13.5%
ROCE18.8%17.6%
Net Margin12.03%19.03%
Operating Margin17.6%34.4%
Debt to Equity0.05x0.03x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDGNVIMTALABS
Promoter Holding35.67% 0.18 pp
FII Holding9.91% 0.36 pp4.42% 0.47 pp
DII Holding8.74% 0.44 pp0.37% 0.23 pp
Public Holding81.34% 0.1 pp59.55% 0.43 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indegene Limited and Vimta Labs Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.